Development and Expanding Indications of GLP-1 Receptor Agonists In 2005, the United States (US) Food and Drug Administration approved the first GLP-1 receptor agonist, exenatide, for the treatment of type 2 diabetes (T2D)
This means theres plenty of fuel in your blood, but your cells are under-fueled, leaving you fatigued
Sum-Ping told Healthline that although only the abstract has been published so far, the research shows a lot of promise
Occasional nausea is common with GLP-1 RAs, but persistent vomiting (GLP-1 related or not) can deplete electrolytes significantly.Hyponatremia and hypernatremia (sodium imbalance)Sodium abnormalities typically only occur when significant vomiting, diarrhea, dehydration, or excessive water intake accompany GLP-1 RA use."Sodium can trend low (hyponatremia) if large amounts of free water are consumed without adequate electrolytes, or high (hypernatremia) if fluid intake is inadequate," Dr